Adaptyx Biosciences

Based in the US, Adaptyx Biosciences, Inc.Adaptyx Biosciences, Inc. specializes in wearable health technologies that enable continuous monitoring of critical biomarkers.Adaptyx's core offering is an advanced biochemical monitoring system encapsulated in a wearable patch designed to provide continuous health and biomarker intelligence. The platform transforms traditional lab-grade biochemical assays into a real-time data stream, enabling proactive healthcare management without the need for frequent clinic visits. The patch employs a minimally-invasive dermal probe to analyze interstitial fluid, allowing for the detection of key biomarkers such as hormones, glucose, and drug levels. Targeted use cases include managing chronic conditions like heart failure and chronic kidney disease, as well as monitoring hormone levels and facilitating precision pharmacology in clinical settings.Adaptyx generates revenue through a combination of direct-to-consumer and B2B business models, focusing on partnerships with healthcare institutions and providers. Clients engage with Adaptyx by integrating its wearable patch technology into their patient care protocols, thus facilitating continuous monitoring and data collection that enhances clinical decision-making. The company's revenue structure includes subscription-based services for ongoing access to its data analytics platform, as well as potential bulk purchasing arrangements for healthcare providers that utilize the patches in their practices.In October 2025, Adaptyx Biosciences, Inc. The funds will be utilized to accelerate product development and add more molecular sensors, as well as support clinical trials for its wearable platform. Adaptyx aims to launch new product iterations targeting enhanced monitoring capabilities within the next two years, with plans to expand its market presence into Asia and South America by 2026.

1. Seed

   Oct 20, 2025

   Amount

   $14M

   Investors

   Locked